SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
70 hedge funds and large institutions have $291M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
35% less capital invested
Capital invested by funds: $446M → $291M (-$156M)
Holders
70
Holding in Top 10
3
Calls
$956K
Puts
–
Top Buyers
| 1 | +$8.59M | |
| 2 | +$3.63M | |
| 3 | +$3.5M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$3.1M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$2.36M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$4.46M | |
| 3 | -$3.74M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.97M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.75M |